Sort
15,842 grants matching “pancreatic cancer”
TGFB SIGNALING PATHWAY IN THE PANCREAS
$109,485University Of Michigan At Ann Arbor · K08 · FY2000 · DK
TGFB SIGNALING PATHWAY IN THE PANCREAS
$109,485University Of Michigan At Ann Arbor · K08 · FY2001 · DK
Consortium for the Study of Chronic Pancreatitis: Pittsburgh Clinical Center
$109,320Dhiraj Yadav · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · DK
Prognostic Biomarkers for ZIP4-mediated Cachexia in Pancreatic Cancer
$109,301Min Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · CA
Tissue Core
$109,251Thomas C Smyrk · Mayo Clinic Rochester · P50 · FY2014 · CA
Core A: Administration, Integration, Education and Career Development
$109,235Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2024 · CA
Targeting B7-H3 in ovarian cancer
$109,227Gianpietro Dotti · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER
$109,200Washington University · R29 · FY2000 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER
$109,200Washington University · R29 · FY2002 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER
$109,200Washington University · R29 · FY2003 · CA
HER2/NEU OVEREXPRESSION AND PANCREATIC CANCER
$109,200Washington University · R29 · FY2001 · CA
Identifying chromatin factors essential for DNA repair using a novel high-throughput screening methodology
$109,080Thomas L Clarke · Massachusetts General Hospital · K99 · FY2022 · ES
Identifying chromatin factors essential for DNA repair using a novel high-throughput screening methodology
$109,080Thomas L Clarke · Massachusetts General Hospital · K99 · FY2023 · ES
Predictive Markers of Response to and Treatment Effects of Motixafortide, Cemiplimab, Gemcitabine and Nab-Paclitaxel in Treatment Naïve Metastatic Pancreatic Cancer
$109,080Michael Stevenson May · Columbia University Health Sciences · K38 · FY2025 · CA
Investigating the metabolic regulation of tumor desmoplasia
$109,072Simon Schwãrer · Sloan-Kettering Inst Can Research · K99 · FY2022 · CA
Investigating the metabolic regulation of tumor desmoplasia
$109,072Simon Schwãrer · Sloan-Kettering Inst Can Research · K99 · FY2021 · CA
Prognostic markers in metastatic melanoma
$108,894Bonnie Elyssa Gould Rothberg · Yale University · K08 · FY2011 · CA
BIND Chemistry for Imaging Intracellular Targets
$108,868Ralph Weissleder · Massachusetts General Hospital · P50 · FY2014 · CA
Exploration of a Mutant p53 Reactivating Compound
$108,739Darren Richard Carpizo · Rbhs -Cancer Institute Of New Jersey · K08 · FY2016 · CA
Tissue Modeling Core
$108,731Hernan Alcides Flores-Rozas · Florida Agricultural And Mechanical Univ · U54 · FY2021 · CA
GEMCITABINE POTENTIATION OF PRETARGET RIT
$108,679Neorx Corporation · R43 · FY2001 · CA
Developmental Fund
$108,632Elizabeth Marion Jaffee · Johns Hopkins University · P50 · FY2014 · CA
Mechanisms on the Regulation of PTEN Expression by TGF-Beta
$108,498Yip Chow · University Of California, San Diego · K01 · FY2008 · DK
Revealing cancer metabolism via mass spectrometry and isotope tracers
$108,427Wenyun Lu · Princeton University · R50 · FY2020 · CA
Revealing cancer metabolism via mass spectrometry and isotope tracers
$108,427Wenyun Lu · Princeton University · R50 · FY2016 · CA